DMC Healthcare Dermatology Service update


Dear Colleagues,

DMC Healthcare is committed to supporting GPs throughout the COVID-19 outbreak. Patients unattended during this C19 crisis may suffer deterioration of their skin diseases and experience delays in referral to cancer pathways. We are also aiming to reduce the size of the predicted backlog once normal services resume post C19.

In order to maintain the Dermatology services for your area we are now seeing patients remotely.  Upon receipt of a referral from primary care we will offer patients the opportunity to have a remote consultation with our consultants via video or telephone with images. Those patients who are unable to access the necessary IT for a remote consultation, will be added to a deferred waiting list for a face to face appointment when it becomes safe to do so.

There may be occasions when we need support from primary care to assist with the issuing of prescriptions and phlebotomy services to ensure we can support our patients wherever possible. We ask that you work with our consultants during this time to avoid delay of care to patients.

Please be advised that during this time we are following BAD guidelines and have suspended all Isotretinoin treatment as this is believed to dry the mucosal areas, making the patient more susceptible to contracting COVID-19.

Telephone lines for patients remain open as usual and there are regular information updates on our website https://dmchealthcare.co.uk and social media platforms.    If you have any queries relating to a referral please email us on: dmc.admin1@nhs.net  

Kind regards,

Dr Nadeem Moghal
MBChB BAO (MRCP) FRCPCH MBA FRCPI (Hon.)
Chief Executive.